Vigilant Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Vigilant Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$1K	–	528
2018 Q3	$1K	Buy	+10,000	New	+$1K	﹤0.01%	453

Vigilant Capital Management's ANTH Position: Q4 2018 in Review

Vigilant Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2018, closing a stake of 10,000 shares — an estimated $1K sold.

Vigilant Capital Management first reported a position in ANTH in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 0 funds tracked by Wall St. Rank hold ANTH as of Q4 2018.

Vigilant Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Vigilant Capital Management sold 10,000 Anthera Pharmaceuticals, Inc. shares in Q4 2018, an estimated $1K.
Vigilant Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2018 and held it in 1 quarter.
Vigilant Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $1K in Q3 2018.
0 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2018.

Based on Vigilant Capital Management's 13F filing for Q4 2018, filed 15 Jan 2019.